Does BASILIXIMAB Cause Post transplant lymphoproliferative disorder? 192 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 192 reports of Post transplant lymphoproliferative disorder have been filed in association with BASILIXIMAB (Simulect). This represents 2.8% of all adverse event reports for BASILIXIMAB.
192
Reports of Post transplant lymphoproliferative disorder with BASILIXIMAB
2.8%
of all BASILIXIMAB reports
58
Deaths
72
Hospitalizations
How Dangerous Is Post transplant lymphoproliferative disorder From BASILIXIMAB?
Of the 192 reports, 58 (30.2%) resulted in death, 72 (37.5%) required hospitalization, and 21 (10.9%) were considered life-threatening.
Is Post transplant lymphoproliferative disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BASILIXIMAB. However, 192 reports have been filed with the FAERS database.
What Other Side Effects Does BASILIXIMAB Cause?
Cytomegalovirus infection (590)
Drug ineffective (567)
Off label use (567)
Transplant rejection (554)
Kidney transplant rejection (456)
Product use in unapproved indication (428)
Pyrexia (323)
Diarrhoea (314)
Multiple organ dysfunction syndrome (298)
Polyomavirus-associated nephropathy (298)
What Other Drugs Cause Post transplant lymphoproliferative disorder?
TACROLIMUS (2,529)
MYCOPHENOLATE MOFETIL (1,762)
PREDNISONE (1,441)
CYCLOSPORINE (957)
PREDNISOLONE (772)
RITUXIMAB (719)
CYCLOPHOSPHAMIDE (667)
METHYLPREDNISOLONE (506)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (439)
MYCOPHENOLIC ACID (438)
Which BASILIXIMAB Alternatives Have Lower Post transplant lymphoproliferative disorder Risk?
BASILIXIMAB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH
BASILIXIMAB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED
BASILIXIMAB vs BCG VACCINE
BASILIXIMAB vs BEBTELOVIMAB
BASILIXIMAB vs BECLOMETHASONE